fluoxetine and epigallocatechin gallate

fluoxetine has been researched along with epigallocatechin gallate in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Delabar, JM	1
Bianchi, DW; Delabar, JM; Guedj, F	1
Hassan, ESG; Hassanein, NM; Sayed Ahmed, HM	1

Reviews

2 review(s) available for fluoxetine and epigallocatechin gallate

Article	Year
[New perspectives on molecular and genic therapies in Down syndrome]. Medecine sciences : M/S, 2010, Volume: 26, Issue:4 Topics: Animals; Catechin; Chromosomes, Human, Pair 21; Disease Models, Animal; Down Syndrome; Droxidopa; Drug Delivery Systems; Fluoxetine; Forecasting; Gene Expression Regulation; Genetic Association Studies; Genetic Therapy; Hedgehog Proteins; Humans; Memantine; Mice; Mice, Transgenic; Models, Genetic; Neuronal Plasticity; Neurotransmitter Agents; Pentylenetetrazole; Phenotype; Signal Transduction	2010
Prenatal treatment of Down syndrome: a reality? Current opinion in obstetrics & gynecology, 2014, Volume: 26, Issue:2 Topics: Animals; Animals, Newborn; Apigenin; Catechin; Choline; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Female; Fluoxetine; Humans; Mice; Mice, Transgenic; Molecular Targeted Therapy; Neural Stem Cells; Neurogenesis; Neuroprotective Agents; Oxidative Stress; Pregnancy; Prenatal Care; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Stem Cell Transplantation	2014

Article

Year

[New perspectives on molecular and genic therapies in Down syndrome].

Medecine sciences : M/S, 2010, Volume: 26, Issue:4

Topics: Animals; Catechin; Chromosomes, Human, Pair 21; Disease Models, Animal; Down Syndrome; Droxidopa; Drug Delivery Systems; Fluoxetine; Forecasting; Gene Expression Regulation; Genetic Association Studies; Genetic Therapy; Hedgehog Proteins; Humans; Memantine; Mice; Mice, Transgenic; Models, Genetic; Neuronal Plasticity; Neurotransmitter Agents; Pentylenetetrazole; Phenotype; Signal Transduction

2010

Prenatal treatment of Down syndrome: a reality?

Current opinion in obstetrics & gynecology, 2014, Volume: 26, Issue:2

Topics: Animals; Animals, Newborn; Apigenin; Catechin; Choline; Disease Models, Animal; Down Syndrome; Dyrk Kinases; Female; Fluoxetine; Humans; Mice; Mice, Transgenic; Molecular Targeted Therapy; Neural Stem Cells; Neurogenesis; Neuroprotective Agents; Oxidative Stress; Pregnancy; Prenatal Care; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, GABA; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Stem Cell Transplantation

2014

Other Studies

1 other study(ies) available for fluoxetine and epigallocatechin gallate

Article	Year
Probing the chemoprevention potential of the antidepressant fluoxetine combined with epigallocatechin gallate or kaempferol in rats with induced early stage colon carcinogenesis. Journal of pharmacological sciences, 2021, Volume: 145, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Chemoprevention; Colon; Colonic Neoplasms; Dimethylhydrazines; Fluoxetine; Kaempferols; Male; Phytotherapy; Rats, Sprague-Dawley	2021

Article

Year

Probing the chemoprevention potential of the antidepressant fluoxetine combined with epigallocatechin gallate or kaempferol in rats with induced early stage colon carcinogenesis.

Journal of pharmacological sciences, 2021, Volume: 145, Issue:1

Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Chemoprevention; Colon; Colonic Neoplasms; Dimethylhydrazines; Fluoxetine; Kaempferols; Male; Phytotherapy; Rats, Sprague-Dawley

2021